ARTICLE | Finance
IPO queue grows as Seaport, Hemab line up NASDAQ offerings
Volatility risk may be abating; Kailera, Alamar propose terms
April 13, 2026 10:29 PM UTC
After weeks of inactivity, the queue of biotechs hoping to list on NASDAQ has begun to grow again.
According to a pair of prospectuses filed late Friday, neuropsychiatric start-up Seaport Therapeutics Inc. and coagulation disorders company Hemab Therapeutics Holdings Inc. are each looking to raise cash in IPOs...
BCIQ Company Profiles